Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01044732 · ClinicalTrials.gov registry record · NA
Third Eye Retroscope Randomized Clinical Evaluation
A NA study, sponsored by Avantis Medical Systems.
- Completed
- Registry status
- NA
- Development phase
- 448
- Enrollment target
NCT01044732: Completed NA study, sponsored by Avantis Medical Systems.
NCT01044732 is a NA study that has completed, run by Avantis Medical Systems. The registered enrollment target is 448 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01044732, a NA study, has completed, sponsored by Avantis Medical Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 448 participants
- Enrollment target
Study Summary
The Third Eye® Retroscope® is a device that can be inserted through the instrument channel of a standard colonoscope to provide an additional, retrograde (or backward) view that reveals areas behind folds and flexures in the colon, and might detect additional polyps that cannot be seen with the colonoscope alone. Patients who participate as subjects in the study will undergo two complete colonoscopy procedures, a standard colonoscopy and a colonoscopy in which a Third Eye Retroscope is used along with the same colonoscope. Half of the patients will have the standard colonoscopy first followed by the Third Eye colonoscopy, and the other half will have the Third Eye procedure first. Results from the two groups will be analyzed and compared to determine the effectiveness of the Third Eye Retroscope for detecting additional adenomas and other polyps compared with the standard colonoscope alone.
Primary Outcome
Numbers of polyps and adenomas detected in first and second procedures for each group
Interventions
- DEVICE Third Eye Retroscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 448 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-02 |
| Phase | NA |
What the finished NCT01044732 record still lists
NCT01044732 is an interventional study that assigns participants to a tested intervention. The registered 448 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 1 intervention - of which Third Eye Retroscope is the first listed.
NCT01044732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01044732 about?
NCT01044732 is a clinical study titled "Third Eye Retroscope Randomized Clinical Evaluation". The Third Eye® Retroscope® is a device that can be inserted through the instrument channel of a standard colonoscope to provide an additional, retrograde (or backward) view that reveals areas behind folds and flexures in the colon, and might detect additional polyps that cannot be seen with the colo...
What is the current status of trial NCT01044732?
This trial is currently completed. It is a NA study. The enrollment target is 448 participants. The study started on 2009-03. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01044732?
The interventions under investigation include: Third Eye Retroscope (DEVICE).
Who is sponsoring clinical trial NCT01044732?
This trial is sponsored by Avantis Medical Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01044732's enrollment target sits among peer trials
448 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702449 · 448 participants · Phase 1
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- NCT07125053 · 448 participants · NA
COPD Resources, Education, and Activity Designed for You Study
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia